Study Comparing Zevalin Regimen With no Further Treatment in Patients With Diffuse Large B-cell Lymphoma.

Clinical trial NCT00322218 · TERMINATED

Trial details

NCT number: NCT00322218
Sponsor: Spectrum Pharmaceuticals, Inc
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Lymphoma, Large Cell, Diffuse

Start date: 2006-05-01
Primary completion: 2008-12-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.